SCHEMBL7696264

SCHEMBL7696264

Clc1ccc(NNc2cnc3cc4ccccc4cc3n2)c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PDGFRB P09619 3/20 0.40
PDGFRA P16234 3/20 0.40
THRB P10828 1/20 0.38
MAPK1 P28482 1/20 0.38
ALDH1A1 P00352 3/20 0.37
LMNA P02545 2/20 0.37
GAA P10253 1/20 0.37
RAB9A P51151 4/20 0.36
NPC1 O15118 3/20 0.36
ALPL P05186 1/20 0.36
CYP2A6 P11509 1/20 0.36
KDM4E B2RXH2 1/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.35
PPARG P37231 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7699339 0.87 PDGFRB (0.46) PDGFRBPDGFRATHRBMAPK1LMNA
SCHEMBL7692581 0.81 PDGFRB (0.43) MAPTTDP1L3MBTL1MEN1KMT2A
SCHEMBL7696498 0.79 PDGFRB (0.55) MEN1KMT2APDGFRBPDGFRA
SCHEMBL7106618 0.75 PDGFRB (0.53) L3MBTL1PDGFRBPDGFRATHRBMAPK1
SCHEMBL7695428 0.74 MAPKAPK2 (0.44) MAPTMEN1KMT2APDGFRBPDGFRA
SCHEMBL7695393 0.74 PDGFRB (0.59) MAPTMEN1KMT2APDGFRBPDGFRA
SCHEMBL7699322 0.71 PDGFRB (0.71) MEN1KMT2APDGFRBPDGFRA
SCHEMBL7691206 0.70 KDM4E (0.43) MAPTL3MBTL1MEN1KMT2APDGFRB
SCHEMBL10439752 0.69 ALDH1A1 (0.65) MAPTTDP1L3MBTL1MEN1KMT2A
SCHEMBL7694543 0.69 PDGFRB (0.52) KMT2APDGFRBPDGFRARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed